SL Science Holding Ltd
SLBTHealthcare|Biotechnology|US
$0.94
+0.04 (+4.16%)
About
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Stock Price
-88.0%(1Y)
1M
-38.3%
3M
-64.9%
6M
-88.0%
YTD
-88.0%
1Y
-88.0%
3Y
-88.0%
5Y
-88.0%
Pipeline Summary
2 total trials0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
Completed: 1Not Yet Recruiting: 1
Key Facts
Market Cap$525.7M
Employees20
CEOWilliam Wang
IPO DateFeb 5, 2025
Beta0.09
52-Week Range$0.74 – $14.5
Avg Volume585,019
ExchangeNASDAQ
Websitesl-bio.com
Ownership
Float40.5%
Shares Outstanding560.8M
Recent Insider Trades
Hung Chin-ShengOTHER
Nov 1, 20260 shares
Shen Ethan PhDOTHER
Nov 1, 20260 shares
Wang Ching-DongBUY
Sep 29, 20264,545,306 shares @ $0.50
LAU JOHNSON SHUN-PONGOTHER
Aug 31, 20260 shares
Wang Ching-DongOTHER
Jun 12, 20260 shares
Peers
Recent News
SL Science Holding Limited Reports First Half 2026 Financial Results
Oct 26, 2026 · globenewswire.com
SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma
Sep 24, 2026 · globenewswire.com
SL Science: A $1.15 Billion Valuation Built On Preclinical Promises
Sep 16, 2026 · seekingalpha.com
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
Sep 2, 2026 · globenewswire.com
Data last updated: Nov 9, 2026, 04:34 AM